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of polyphenol intake, but a linear association was found 
only for BMI and WC. After adjusting for potential con-
founding factors, individuals in the highest quartile of 
polyphenol intake were less likely to have MetS (OR 0.80; 
95 % CI 0.64, 0.98 and OR 0.70; 95 % CI 0.56, 0.86 for 
both men and women, respectively). High total polyphenol 
intake was negatively associated with WC, blood pressure, 
high lipoprotein cholesterol, and triglycerides in women, 
and fasting plasma glucose in both genders. Among indi-
vidual classes of polyphenols, phenolic acids and stilbenes 
were significantly associated with MetS; lignans and stil-
benes with WC; phenolic acids with blood pressure and 
triglycerides; and flavonoids with fasting plasma glucose. 
Among specific subclasses of polyphenols, hydroxycin-
namic acids, flavanols, and dihydrochalcones had the most 
relevant role.
Conclusions Total and individual classes and subclasses 
of dietary polyphenols were inversely associated with MetS 
and some of its components.
Keywords Dietary polyphenols · Flavonoids · Phenolic 
acids · Stilbenes · Lignans · Metabolic syndrome · 
Blood pressure · Waist circumference · Dyslipidemia · 
Hyperglycemia
Introduction
Metabolic syndrome (MetS) is a condition characterized by 
a cluster of cardiovascular risk factors, including impaired 
glucose metabolism, dyslipidemia, elevated blood pressure, 
and abdominal obesity [1]. The prevalence of MetS has 
increased over the last decades up to 30 % among Euro-
pean adults together with rise of obesity trends [2]. MetS 
has become a major worldwide public health problem 
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due to its association with increased risk of cardiovascu-
lar disease and cancers related to metabolic impairment 
[3]. Among the main determinants, sedentary lifestyle and 
overnutrition seem to be mostly responsible for this path-
ological condition [4]. However, existing knowledge of 
pathogenic mechanisms associated to MetS is controver-
sial and not uniformly accepted. Findings from current evi-
dence agree that the complex interplay between adipokines 
and adipocytokines characterizing obesity status occurring 
in MetS leads to a chronic low-grade inflammation with 
permanently increased oxidative stress [5]. Overexpres-
sion of oxidative stress damages cellular structures, asso-
ciated with underproduction of antioxidant mechanisms, 
which are supposed to be key features for the development 
of obesity-related complications [5]. This may explain why 
plant-based dietary patterns have been demonstrated to 
protect against MetS and its individual components [6, 7]. 
Together with a decreased caloric intake, high consumption 
of antioxidant compounds has been hypothesized to play 
an important role in preventing this pathological condition 
[8–10].
Polyphenols are antioxidant compounds contained in 
foods and beverages commonly consumed by humans. 
These compounds are divided into five main classes 
according to their chemical structure: flavonoids, phe-
nolic acids, stilbenes, lignans, and others [11]. Recently, 
polyphenol consumption has been the focus of attention 
as an attractive explanation for the benefits conferred not 
only by plant foods, but also beverage, such as coffee, 
tea, and beer [4, 12–16]. Several experimental studies 
provided the biological plausibility for their potential 
role in preventing components of MetS [17–20]. Poly-
phenols have been hypothesized to exert antioxidant 
and antiinflammatory effects, as well as to explain diet–
genes interactions as first indication for the impact of 
such compounds on metabolic-associated comorbidities 
[21–23]. Epidemiological investigations are in line with 
experimental studies, but most of the significant find-
ings are limited to the effects of flavonoids consump-
tion on diabetes [24], whereas results on hypertension 
are controversial [25–29]. However, there is no universal 
consensus among studies, as most of them used differ-
ent nutrient databases that may lead to high variability 
of estimated dietary intake of compounds. Overall, evi-
dence showing the association of all main polyphenol 
classes with MetS and its components is scarce. To date, 
only one study investigated the association between total 
and individual classes of polyphenols and MetS [30] 
reporting inconclusive results for overall dietary poly-
phenol intake although significant associations between 
flavonoids intake and all MetS components were found. 
Findings are promising, but comprehensive analyses on 
the relation of the main polyphenol groups and meta-
bolic status are lacking.
The aim of this study was to evaluate whether total and 
individual classes of dietary polyphenol intake was asso-
ciated with MetS in a large cohort of urban Polish adults. 
The association of polyphenol intake with components of 
MetS, including body mass index (BMI), waist circumfer-
ence (WC), fasting plasma glucose (FPG), total choles-
terol, HDL cholesterol (HDL-c), LDL cholesterol (LDL-c), 
serum triglycerides (TG), and systolic and diastolic blood 
pressure (SBP and DBP, respectively), was also explored.
Subjects and methods
Study population
Subjects were participants of the Polish arm of the Health, 
Alcohol and Psychosocial factors In Eastern Europe (HAP-
IEE) study, which was a prospective cohort study aimed 
to investigate the determinants of CVD and other chronic 
conditions in Central and Eastern Europe. The study pro-
tocol with the rationale, design, and methods has been 
described in detail elsewhere [31]. Briefly, a random sam-
ple of 10,728 subjects (aged 45–69 years) was recruited 
at the baseline survey conducted in 2002–2005 (response 
ratio of 59 %) in the urban area of Kraków, Poland. The 
survey involved completion of structured questionnaires 
and an examination in clinic. The questionnaires covered 
health, medical history, health behavior, socioeconomic cir-
cumstances, psychosocial factors, and diet. The participants 
provided written informed consent, and the study protocol 
was approved by the ethics committee at University Col-
lege London, UK, and by the bioethics committee of the 
Jagiellonian University (no. KE/99/03/B/284 2).
Among participants who attended the clinical visit 
(n = 9050), those with missing outcome measures with 
incomplete (more than 50 % of answers missing) or incon-
gruent (energy intake <500/>4000 kcal/day for females 
and <800/>5000 kcal/day for males) data regarding dietary 
information were excluded, resulting in a final sample of 
8821 adults (51.4 % female).
Demographic, lifestyle, and clinical measurements
Sociodemographic and lifestyle characteristics included 
age, gender, educational and occupational level, smok-
ing and alcohol drinking habits. Educational level was 
categorized as (a) low (primary/secondary), (b) medium 
(high school), and (c) high (university). Occupational level 
was categorized as (a) low (unskilled/unemployed work-
ers), (b) medium (partially skilled workers), and (c) high 
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(skilled workers). Physical activity level was calculated 
by taking into account energy expenditure from activi-
ties both at work and leisure time, frequency (times per 
week converted in daily), duration (minutes per time), and 
intensity (expended calories). Intensity was categorized in 
light [expended energy <16.7 kJ (<4 kcal)/min], moder-
ate [expended energy 16.7–29.3 kJ (4–7 kcal)/min], and 
high [expended energy >29.3 kJ (7 kcal)/min]. A com-
bined score by multiplying weekly frequency, duration, and 
intensity of physical activity was calculated and individu-
als gradated in qualitative terms such as (a) low, (b) mod-
erately, and (c) highly active. Individuals were categorized 
according to their smoking status as non-smoker or current 
smoker. Alcohol consumption was categorized as (a) up to 
or (b) more than 12 g/day.
The physical examination included measurement of 
height, weight, waist circumference (WC), and blood pres-
sure using standard procedures [31]. BMI was calculated 
according the formula weight (kg)/height2 (m). WC was 
measured midway between the 12th rib and the iliac crest. 
Blood pressure was measured three times at the end of the 
physical examination, and the final value was the mean 
among the three measurements.
Dietary assessment
Dietary data were collected by using a food frequency 
questionnaire (FFQ) based on the tool developed by Wil-
lett et al. [32] and subsequently adapted in the Whitehall II 
Study [33]. The FFQs consisted of a 148 food- and drink-
item. An instruction manual that included photographs to 
facilitate the estimation of portion sizes was used. Par-
ticipants were asked how often, on average, they had con-
sumed that amount of the item during the last 3 months, 
with nine responses ranging from “never or less than once 
per month” to “six or more times per day”. Moreover, par-
ticipants were asked to include additional foods and fre-
quency of consumption by manual entry.
Estimation of polyphenol intake
Data on the polyphenol content in foods were obtained 
from the Phenol-Explorer database (www.phenol-explorer.
eu) [34]. The process of estimation of polyphenol intake 
has been described in details elsewhere [35]. Briefly, food 
items of the FFQ containing more food components were 
separated according to their ingredients, and foods that 
contained no polyphenols were excluded from the analysis.
The average food consumption was calculated (in gram 
or milliliter) by following the standard portion sizes used in 
the study and then converted in 24-h intake. An advanced 
search was carried out in the Phenol-Explorer database to 
retrieve mean content values for all polyphenols contained 
in the foods obtained, and individual polyphenol intake 
from each food was calculated by multiplying the con-
tent of each polyphenol by the daily consumption of each 
food. Total polyphenol intake was calculated as the sum 
of all individual polyphenol intakes from all food sources 
encountered according to this process.
Definition of MetS
MetS was defined according to the International Diabe-
tes Federation definition [36]. as having central obesity 
(WC ≥90 cm in men and ≥80 cm in women) and any two of 
the following: (a) TG >150 mg/dL (1.7 mmol/L), or specific 
treatment for this lipid abnormality; (b) HDL-c <40 mg/
dL (1.03 mmol/L) in males, <50 mg/dL (1.29 mmol/L) 
in females, or specific treatment for this lipid abnormal-
ity; (c) SBP >130 or DBP >85 mm Hg, or treatment of 
previously diagnosed hypertension; (d) FPG >100 mg/dL 
(5.6 mmol/L), or previously diagnosed type 2 diabetes or 
treatment of previously diagnosed diabetes.
Statistical analysis
Analyses were performed using SPSS software version 
17.0 (Chicago, IL, USA). Total and specific classes of 
polyphenol intake were adjusted for total energy intake 
(calories) using the residual method, and individuals were 
divided according quartiles of consumption. Baseline char-
acteristics are presented as means and standard deviations 
(SDs) for continuous variables and frequencies for categor-
ical variables across quartiles of total polyphenol intake. 
Variables were examined for normality distribution (Kol-
mogorov–Smirnov), and differences between categories 
were tested by ANOVA test for continuous variables and by 
the Chi square test for categorical variables.
Linear trends across the quartiles of total polyphenol 
consumption categories were tested by assigning each par-
ticipant the median of the category and modeling this value 
as a continuous variable. Multivariable linear regression 
models were performed to assess the relationship between 
metabolic parameters [BMI, WC, HDL-c, FPG, SBP, DBP, 
low-density lipoprotein cholesterol (LDL-c), and total cho-
lesterol (TC)] as dependent variables and 1-SD increase of 
total polyphenol intake as continuous variable. Results from 
the regression models were presented as β-coefficients and 
SE. Normality of the standardized residuals was assessed 
using the Shapiro–Wilk test. The assumption of linearity 
for the continuous independent variables and of the vari-
ance of the standardized residuals being constant was 
assessed through plotting the residuals against the fitted 
values. Finally, odds ratios (ORs) and 95 % confidence 
intervals (CIs) assessing the association of both categorized 
polyphenol intake and 1-SD increase, with having MetS or 
1412 Eur J Nutr (2017) 56:1409–1420
1 3
its individual components, were calculated by multivariable 
logistic regression models. Gender-specific analyses were 
also conducted to take into account the natural differences 
in body composition and caloric needs between men and 
women. An additional analysis was performed using quar-
tiles of specific polyphenol classes in order to test whether 
associations relied on specific groups rather than total con-
sumption. All regression models were adjusted for potential 
confounders, such as age, gender, education, occupation, 
physical activity, smoking status, and total energy intake. 
Further additional adjustments by foods mainly contribut-
ing to polyphenol content were performed to test whether 
dietary factors could influence the retrieved associations. 
Multivariable regression models including specific poly-
phenol classes included also adjustment for each other 
polyphenol class. All reported P values were based on two-
sided tests and compared to a significance level of 5 %.
Results
Baseline characteristics of the 8821 subjects included in the 
analysis by quartiles of polyphenol consumption are given 
in Table 1. Compared with lower quartiles, a higher per-
centage of individuals in the higher quartile of polyphenol 
intake had lower age and higher energy intake. Moreover, 
among women consuming more dietary polyphenols, there 
was a significantly lower percentage of non-smoker. No 
significant differences were found regarding educational 
and occupational status, as well with alcohol consumption 
habits (Table 1).
The analysis of the association between various meta-
bolic parameters and total dietary polyphenol consumption 
revealed an association with BMI (P = 0.023 and P < 0.001 
in men and women, respectively), WC (P = 0.025 
and P < 0.001 in men and women, respectively), SBP 
(P = 0.034 and P < 0.001 in men and women, respec-
tively), DBP (P = 0.010 in women), and TG (P = 0.001; 
Table 2). When the relation was tested as linear association, 
only BMI and WC remained significant, suggesting that 
differences in blood pressure and TG among polyphenols 
quartiles may be stronger among individuals falling into 
extreme categories (Table 2).
Individuals consuming higher quantities of polyphenols 
were less likely to have MetS (highest vs. lowest quartile, 
OR 0.74; 95 % CI 0.64, 0.86; Table 3). The multivariate-
adjusted regression analysis revealed that the highest quar-
tile of intake was significantly associated with several com-
ponents of MetS, such as WC, blood pressure, TG, and 
FPG (Table 3). When the analysis was stratified by gender, 
polyphenol consumption was significantly associated with 
individual components of MetS only in women, although 
association with MetS was significant in both genders 
(highest vs. lowest quartile, OR 0.80; 95 % CI 0.64, 0.98 
and OR 0.70; 95 % CI 0.56, 0.86 in men and women, 
respectively; Table 3). The specific analysis of individual 
classes of polyphenols revealed certain differences in the 
effect of various groups toward MetS and its components 
(Table 4). In fact, only highest intake of phenolic acids and 
stilbenes was significantly associated with MetS, whereas 
analysis for each MetS component demonstrated a signifi-
cant association of highest intake of lignans and stilbenes 
with WC, phenolic acids with blood pressure and TG, and 
flavonoids with FPG (Table 4). Overall, the linear associa-
tion among the various polyphenol classes was maintained 
only for phenolic acids and, partially, flavonoids, whereas 
other classes demonstrated no significant linear association 
(Table 4). Among phenolic acids, hydroxycinnamic acids 
resulted significantly linearly associated with having MetS 
and, among its components, WC, blood pressure, and TG 
(Supplementary Table 1). Among flavonoids, the stronger 
association with MetS was found for intake of flavanols, 
which effect was related to FPG and, not linearly, with WC, 
whereas nonlinear associations were also found between 
dihydrochalcones and blood pressure (Supplementary 
Table 2).
In order to relate these findings to foods consumed by 
the study cohort, the main food sources of total and indi-
vidual classes and subclasses of polyphenols were finally 
given in Table 5. Overall, coffee and tea represented the 
major sources of total dietary polyphenol intake, whereas 
other foods, such as apples and oranges, were among 
the main sources of more than one subclass of polyphe-
nols. These foods were present in several of the polyphe-
nol groups that were significantly associated with MetS 
and thus among the main candidates in this cohort to be 
mostly responsible for potential protection against meta-
bolic disorders. When analyses to test the association 
between total polyphenol intake and MetS and its com-
ponents were further adjusted by the main food contribu-
tors to the polyphenol content (Supplementary Table 3), 
only coffee and tea intake affected the results, despite not 
significantly.
Discussion
In the present study, we evaluated the relationship between 
total and individual classes of dietary polyphenol consump-
tion and MetS and its components in a large urban cohort 
of men and women living in Krakow, Poland. A significant 
inverse association between high polyphenol intake and 
MetS was found. The analysis interesting individual classes 
of polyphenols revealed that those mostly responsible for 
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such association were phenolic acids, flavonoids, and stil-
benes. Moreover, association of individual polyphenol 
classes and MetS components has been found.
Although confounders such as age, educational status, 
physical activity, and smoking were related, in various 
ways, to outcomes examined in this study, total polyphe-
nol intake resulted independently associated with MetS 
and some of its components, including WC, blood pres-
sure, and lipid and glucose alterations. Individual phe-
nolic compounds have been previously associated with 
reduced risk of metabolic disorders in both cohort and ran-
domized controlled trials conducted on multiple metabolic 
outcomes, such as glycaemic control [37–39], blood pres-
sure [40, 41], and lipid profile [42]. However, data on total 
polyphenol intake and metabolic outcomes are scarce. In 
the PREDIMED study, total polyphenol urine excretion 
was related to plasma nitric oxide (NO), which in turn 
was associated with a reduction in systolic and diastolic 
blood pressure levels [43]. Total polyphenol intake has 
been also inversely associated with a score of low-grade 
inflammation biomarkers in the Moli-sani cohort, which 
would provide the rationale for the health benefits of 
these compounds. Nonetheless, only one study specifi-
cally explored the association of total polyphenol intake 
Table 3  Multivariate adjusted odds ratios (95 % confidence interval)a for metabolic syndrome and its individual components by quartiles of 
total polyphenol intake (Q1–Q4) and 1-SD increment, overall and by gender
DBP diastolic blood pressure, FPG fasting plasma glucose, HDL-c high-density lipoprotein cholesterol, SBP systolic blood pressure, SD stand-
ard deviation, TG triglycerides, WC waist circumference
a Adjusted for age, gender (except when analyses were stratified by sex), education, physical activity, smoking status, alcohol drinking, body 
mass index, and total energy intake
Total polyphenol intake 1-SD increase
Q1 Q2 Q3 Q4
Metabolic syndrome
 No. cases (%) 679 (31.3) 638 (29.1) 615 (27.4) 529 (23.0)
 Overall 1 0.89 (0.78–1.03) 0.85 (0.74–0.98) 0.74 (0.64–0.86) 0.90 (0.85, 0.96)
 Men 1 0.82 (0.67–1.00) 0.89 (0.73–1.09) 0.80 (0.64–0.98) 0.83 (0.96, 0.99)
 Women 1 0.96 (0.80–1.17) 0.82 (0.67–0.99) 0.70 (0.56–0.86) 0.90 (0.83, 0.97)
WC (≥90 cm in men, ≥80 cm in women)
 No. cases (%) 880 (40.6) 857 (39.1) 851 (37.9) 753 (34.0)
 Overall 1 0.93 (0.82–1.06) 0.91 (0.79–1.03) 0.80 (0.69–0.92) 0.93 (0.88, 0.97)
 Men 1 0.93 (0.76–1.13) 1.03 (0.85–1.25) 0.85 (0.69–1.05) 0.94 (0.88, 1.01)
 Women 1 0.94 (0.79–1.12) 0.81 (0.67–0.97) 0.76 (0.63–0.92) 0.93 (0.87, 0.99)
SBP (≥130 mmHg) or DBP (≥85 mmHg or hypertensive treatment)
 No. cases (%) 1390 (64.1) 1381 (63.0) 1315 (58.5) 1255 (56.7)
 Overall 1 0.96 (0.84–1.10) 0.82 (0.72–0.94) 0.83 (0.72–0.96) 0.93 (0.88, 0.97)
 Men 1 0.94 (0.77–1.15) 0.85 (0.70–1.04) 0.92 (0.75–1.13) 0.95 (0.89, 1.02)
 Women 1 0.98 (0.82–1.18) 0.80 (0.66–0.96) 0.76 (0.63–0.92) 0.90 (0.84, 0.97)
HDL-c (<40 mg/dl in men, <50 mg/dl in women)
 No. cases (%) 490 (22.6) 459 (20.9) 530 (23.6) 476 (21.5)
 Overall 1 0.87 (0.75–1.02) 1.01 (0.87–1.20) 0.90 (0.77–1.05) 0.97 (0.91, 1.02)
 Men 1 0.91 (0.72–1.15) 1.13 (0.90–1.42) 1.03 (0.82–1.31) 0.99 (0.91, 1.07)
 Women 1 0.84 (0.69–1.02) 0.92 (0.76–1.13) 0.80 (0.64–0.99) 0.94 (0.87, 1.02)
TG (≥150 mg/dl)
 No. cases (%) 1038 (47.9) 1025 (46.8) 1013 (45.1) 956 (43.2)
 Overall 1 0.97 (0.85–1.09) 0.90 (0.79–1.02) 0.87 (0.76–0.99) 0.97 (0.92, 1.01)
 Men 1 1.03 (0.86–1.23) 0.98 (0.82–1.17) 0.97 (0.80–1.18) 0.98 (0.92, 1.04)
 Women 1 0.92 (0.77–1.09) 0.84 (0.70–1.00) 0.78 (0.65–0.95) 0.95 (0.89, 1.02)
FPG (≥100 mg/dl or diabetes treatment)
 No. cases (%) 255 (11.8) 221 (10.1) 212 (9.4) 177 (8.0)
 Overall 1 0.85 (0.69–1.04) 0.84 (0.68–1.04) 0.76 (0.60–0.96) 0.93 (0.86, 1.02)
 Men 1 0.84 (0.64–1.10) 0.85 (0.64–1.12) 0.80 (0.59–1.08) 0.95 (0.86, 1.06)
 Women 1 0.86 (0.64–1.17) 0.84 (0.61–1.16) 0.71 (0.49–1.02) 0.93 (0.82, 1.07)
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and MetS in a cohort of Iranian adults, finding no signifi-
cant results, while higher intake of flavonoids, lignans, and 
stilbenes was inversely associated in various ways with 
the outcomes investigated [30]. These results are partially 
in line with those found in the present study although we 
also found that increased intake of phenolic acids demon-
strated inverse association with blood pressure, glucose 
and lipid metabolism, as well as the strongest independent 
association with MetS. Phenolic acids have been reported 
to exert beneficial effects against metabolic disorders 
Table 4  Multivariate adjusted odds ratios (95 % confidence interval)a for metabolic syndrome and its components by quartiles of individual 
polyphenol classes intake (Q1–Q4) and 1-SD increment
DBP diastolic blood pressure, FPG fasting plasma glucose, HDL-c high-density lipoprotein cholesterol, SBP systolic blood pressure, SD stand-
ard deviation, TG triglycerides, WC waist circumference
a Adjusted for age, gender, education, occupation, physical activity, smoking status, alcohol drinking, body mass index, total energy intake, and 
phenolic acids, flavonoids, lignans, stilbenes, and other polyphenol quartiles of intake
Polyphenol intake 1-SD increase
Q1 Q2 Q3 Q4
Metabolic syndrome
 Phenolic acids 1 0.94 (0.82–1.08) 0.98 (0.85–1.13) 0.78 (0.67–0.91) 0.91 (0.86, 0.97)
 Flavonoids 1 0.97 (0.83–1.12) 0.89 (0.76–1.04) 0.88 (0.73–1.00) 0.95 (0.89, 1.00)
 Lignans 1 1.03 (0.89–1.20) 1.01 (0.87–1.18) 0.99 (0.84–1.18) 1.03 (0.98, 1.07)
 Stilbenes 1 0.92 (0.79–1.06) 0.91 (0.79–1.05) 0.83 (0.71–0.96) 1.02 (0.97, 1.08)
 Others 1 1.05 (0.91–1.22) 1.04 (0.89–1.20) 1.07 (0.92–1.25) 0.99 (0.95, 1.04)
WC (≥90 cm in men, ≥80 cm in women)
 Phenolic acids 1 0.98 (0.86–1.12) 0.97 (0.85–1.11) 0.91 (0.79–1.05) 0.96 (0.91, 1.01)
 Flavonoids 1 0.97 (0.85–1.11) 0.95 (0.82–1.10) 0.87 (0.73–1.04) 0.91 (0.86, 0.96)
 Lignans 1 0.93 (0.81–1.06) 0.87 (0.75–1.00) 0.82 (0.70–0.96) 1.04 (0.99, 1.08)
 Stilbenes 1 0.91 (0.80–1.04) 0.87 (0.76–0.99) 0.86 (0.75–0.98) 1.02 (0.97, 1.07)
 Others 1 0.99 (0.86–1.14) 1.02 (0.89–1.18) 1.05 (0.91–1.21) 0.99 (0.96, 1.04)
SBP (≥130 mmHg) or DBP (≥85 mmHg or hypertensive treatment)
 Phenolic acids 1 0.87 (0.76–0.99) 0.88 (0.77–1.01) 0.77 (0.67–0.89) 0.92 (0.88, 0.97)
 Flavonoids 1 0.92 (0.80–1.06) 0.89 (0.76–1.03) 0.99 (0.83–1.18) 0.98 (0.93, 1.03)
 Lignans 1 1.03 (0.89–1.18) 0.99 (0.86–1.15) 1.03 (0.88–1.20) 0.99 (0.96, 1.04)
 Stilbenes 1 0.98 (0.85–1.12) 0.93 (0.81–1.06) 0.95 (0.83–1.09) 0.99 (0.95, 1.05)
 Others 1 0.99 (0.86–1.14) 1.03 (0.89–1.18) 1.04 (0.91–1.20) 1.01 (0.97, 1.05)
HDL-c (<40 mg/dl in men, <50 mg/dl in women)
 Phenolic acids 1 0.94 (0.81–1.09) 1.01 (0.87–1.18) 0.95 (0.81–1.11) 0.97 (0.91, 1.02)
 Flavonoids 1 1.03 (0.88–1.21) 0.88 (0.74–1.05) 0.93 (0.76–1.13) 0.98 (0.93, 1.04)
 Lignans 1 1.06 (0.92–1.24) 1.11 (0.94–1.31) 1.13 (0.95–1.36) 1.01 (0.96, 1.06)
 Stilbenes 1 1.02 (0.88–1.19) 1.10 (0.95–1.28) 0.93 (0.79–1.09) 0.99 (0.93, 1.05)
 Others 1 0.92 (0.78–1.07) 0.92 (0.78–1.08) 0.96 (0.82–1.13) 0.98 (0.93, 1.03)
TG (≥150 mg/dl)
 Phenolic acids 1 1.08 (0.95–1.22) 1.06 (0.94–1.21) 0.87 (0.76–0.99) 0.95 (0.91, 0.99)
 Flavonoids 1 1.01 (0.88–1.15) 0.95 (0.82–1.09) 1.03 (0.88–1.22) 1.01 (0.96, 1.06)
 Lignans 1 1.07 (0.94–1.22) 0.99 (0.87–1.14) 0.96 (0.83–1.21) 1.03 (0.98, 1.07)
 Stilbenes 1 0.99 (0.87–1.13) 0.93 (0.82–1.06) 0.94 (0.83–1.07) 0.99 (0.95, 1.05)
 Others 1 1.11 (0.97–1.27) 1.03 (0.90–1.17) 1.07 (0.93–1.22) 1.01 (0.97, 1.05)
FPG (≥100 mg/dl or diabetes treatment)
 Phenolic acids 1 0.93 (0.76–1.15) 1.04 (0.84–1.28) 0.87 (0.69–1.09) 0.97 (0.89, 1.05)
 Flavonoids 1 0.86 (0.69–1.06) 0.73 (0.57–0.92) 0.71 (0.54–0.94) 0.94 (0.86, 1.03)
 Lignans 1 1.20 (0.96–1.50) 1.27 (1.01–1.61) 1.17 (0.90–1.52) 1.04 (0.99, 1.09)
 Stilbenes 1 1.10 (0.89–1.37) 1.08 (0.87–1.34) 1.07 (0.85–1.33) 0.98 (0.89. 1.09)
 Others 1 1.12 (0.89–1.40) 1.03 (0.82–1.29) 1.10 (0.88–1.38) 1.02 (0.95, 1.09)
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through their antioxidant properties [44] and direct effects 
toward endothelial function and NO bioavailability in the 
arterial vasculature [45], reduced fasting plasma glucose, 
increased sensitivity to insulin, and slowed the appearance 
of glucose in circulation after glucose load [46]. Together 
with phenolic acids, flavonoids showed a significant and 
independent association with the glycaemic impairment, in 
line with previous cohort studies [24]. More recent stud-
ies conducted in the context of the European Prospective 
Investigation into Cancer and Nutrition (EPIC) cohort 
demonstrated similar relations between flavonoids and 
risk of type 2 diabetes [47, 48]. Also results from the US 
cohorts Nurses’ Health Study and the Health Profession-
als’ Follow-up Study demonstrated a decreased risk of dia-
betes for higher intakes of flavonoids [49]. Interestingly, in 
agreement with the aforementioned studies, when analy-
ses were performed on subclasses of flavonoids, the main 
effect on impaired glucose tolerance was driven by fla-
vanols. Flavonoids have been suggested to influence glu-
cose-regulating enzyme activities, uptake of glucose in the 
skeletal muscle, and ameliorate inflammatory status that 
may be cause of insulin resistance [50, 51]. Lignans and 
stilbenes were found to be inversely associated with WC. 
The two classes of polyphenols share some antioxidant 
effects and other properties, such as the capacity of down-
regulate proinflammatory cytokines, increase reverse cho-
lesterol transport, increase insulin sensitivity, and increase 
energy expenditure [52, 53]. Overall, different classes 
of polyphenols exert their main effects by interacting at 
genetic level (i.e., gene activation/deactivation), but intra-
cellular pathways involved in their mechanisms of action 
are only partially described, and the molecular targets of 
these compounds are not completely elucidated.
The large differences in the absorption of subgroups 
of polyphenols may explain their different bioactivity and 
contrasting results among studies. For example, the absorp-
tion of flavanols, usually highly consumed in non-Mediter-
ranean populations, is approximately 100-fold higher than 
proanthocyanidins [54]. Moreover, country-specific food 
preferences have been suggested to enhance consumption 
of specific polyphenol classes among different geographi-
cal regions [55, 56]. We found that main food contributors 
to polyphenol intakes were mostly non-alcoholic bever-
ages, such as tea (responsible for certain flavonoids intake) 
and coffee (responsible for certain phenolic acids intake), 
which accounted for almost 70 % of the total polyphenol 
intake. Further adjustments for these foods partially weak-
ened the associations between total polyphenol intake 
and MetS, high BP and TG, suggesting that the beneficial 
effects of coffee and tea toward metabolic disorders may 
be related to their polyphenol content. However, total 
polyphenol intake was significantly associated with some 
of the aforementioned outcomes, also including high WC 
and impaired FPG, demonstrating an independent role 
of polyphenol intake regardless of their dietary sources. 
Our results are in line with recently published estimation 
of flavonoids intake in the EPIC cohort, where polyphe-
nols deriving by consumption of fruit and vegetables are 
underrepresented in non-Mediterranean compared with 
Mediterranean countries in favor of non-alcoholic bev-
erages [55]. In contrast, the amount of certain phenolic 
acids and flavonoids has been reported to be significantly 
higher in non-Mediterranean compared with Mediterra-
nean countries, accordingly to higher intakes of coffee and 
tea, respectively, as main food sources [13, 57]. Moreo-
ver, dietary intake of polyphenols of individuals living in 
Table 5  Anthropometric 
characteristics and biomarkers 
of metabolic syndrome of the 
study sample by quartiles of 
total polyphenol intake and 
multivariate linear regression 
model with 1-SD increase
Polyphenol class Main food contributors (% contribution to polyphenol class)
Total polyphenols Coffee (40) Tea (27) Chocolate (8)
Flavonoids Tea (48) Chocolate (18) Apples (8)
Anthocyanins Black currant (21) Beans (19) Strawberries (16)
Dihydrochalcones Apple (93) Apple juice (7)
Flavanols Tea (60) Chocolate (25) Apples (7)
Flavanones Orange juice (29) Squash (24) Oranges (23)
Flavones Flour (51) Orange juice (23) Squash (10)
Flavonols Tea (47) Onion (13) Spinach (13)
Isoflavonoids Soy meat (85) Beans (12) Soy milk (3)
Phenolic acids Coffee (66) Tea (12) Vegetable oils (7)
Hydroxybenzoic acids Tea (89) Apples (3) Raspberries (2)
Hydroxycinnamic acids Coffee (75) Vegetable oil (8) Apples (5)
Lignans Seeds (51) Tea (27) Dark bread (8)
Stilbenes Red wine (56) Strawberries (14) White wine (12)
Others Beer (33) Cereals (7) Coffee (3)
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the Mediterranean area has been reported to depend on the 
consumption of certain foods, such as olive oil and nuts, 
which are rich of specific polyphenols poorly represented 
in non-Mediterranean dietary patterns [58, 59]. These dif-
ferences observed in polyphenol bioavailability and food 
sources could partially explain the differences in chronic 
disease risk among countries.
Findings of this study should be considered in light of 
some limitations. First, the cross-sectional nature of the 
study does not allow attributing conclusions to plausible 
causes. Moreover, the low response rate (about 60 %) 
may suggest that information could be representative of 
subjects with better lifestyle habits and health behaviors. 
Thus, the results are only indicative, and the association 
between polyphenols intake and likelihood of having 
MetS needs to be better investigated throughout prospec-
tive studies. Second, the use of a FFQ may lead to recall 
bias and overestimation of food intake. As well, certain 
food products rich in polyphenols were lacking (i.e., 
spices) or grouped (i.e., wine) leading to possible bias 
in the assessment of the total polyphenol intake. Finally, 
the intake of polyphenols may correlate with the intake of 
fruits and vegetables and their constituents, i.e., vitamins, 
folate, and fiber, which may contribute to the association 
with chronic diseases. When the correlation is too high, 
it is difficult to ascertain independent effects of dietary 
components due to the effect of multicollinearity. Future 
large-scale dietary component-based epidemiological 
studies should also take into account other dietary factors 
(both nutrient and non-nutrient) in order to adjust results 
and circumvent multicollinearity problems by identifying 
the effects on metabolic disorders of individual antioxi-
dant compounds.
In conclusion, this study demonstrated that total and 
individual classes of dietary polyphenol intake are associ-
ated with MetS and its components. Although the precise 
molecular mechanisms of action for food polyphenols are 
largely unknown, some functional foods may be considered 
in the early future for safe and effective preventative strat-
egies for metabolic diseases and their cardiovascular and 
oncologic complications. Nevertheless, studies on specific 
classes or individual polyphenols may better clarify the 
potential relation as well as pathways of these compounds’ 
mechanisms of protection.
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